In addition to its role in angiogenesis, VEGF also modulates tumor-induced immunosuppression, thus suggesting immunomodulatory properties of anti-VEGF therapy and opening up new approaches that involve a combination of anti-VEGF agents with immunotherapy (Majidpoor and Mortezaee, 2021). This evidence concerns the gene VEGFA and neoplasm.